aluates Reports

$ 0.0

Automative

Meningitis B Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Published Date: December 2024

Report Code: QYRE-Auto-39E12148

Global Meningitis B Vaccine Market Research Report 2022

BUY CHAPTERS

Meningitis B Vaccine - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Code: QYRE-Auto-39E12148

Report

December 2024

Pages:90

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Sanofi Pasteur，Inc.

Wyeth Pharmaceuticals Inc

BEXSERO

TRUMENBA

GlaxoSmithKline PLC

Pfizer Inc

Novartis

Meningitis B Vaccine - Market Size

The global market for Meningitis B Vaccine was estimated to be worth US$ 23630 million in 2023 and is forecast to a readjusted size of US$ 29030 million by 2030 with a CAGR of 2.9% during the forecast period 2024-2030

Meningitis B Vaccine - Market

Japanese meningitis vaccine is a vaccine used to prevent Japanese encephalitis, and vaccination against Japanese encephalitis is an effective measure to prevent Japanese encephalitis.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Meningitis B Vaccine, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Meningitis B Vaccine by region & country, by Type, and by Application.

The Meningitis B Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Meningitis B Vaccine.

Market Segmentation

Scope of Meningitis B Vaccine - Market Report

Report Metric	Details
Report Name	Meningitis B Vaccine - Market
Forecasted market size in 2030	US$ 29030 million
CAGR	2.9%
Forecasted years	2024 - 2030
Segment by Type:	MenACWY (Conjugate) Vaccine MenB (Recombinant Protein) Vaccine
Segment by Application	Hospital Clinic
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Novartis, BEXSERO, TRUMENBA, Pfizer, Sanofi Pasteur Inc, Wyeth Pharmaceuticals, Inc.
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Meningitis B Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Meningitis B Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Meningitis B Vaccine in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

FAQ for this report

What is the Meningitis B Vaccine - Market size in 2030?

Ans: The Meningitis B Vaccine - Market size in 2030 will be US$ 29030 million.

Who are the main players in the Meningitis B Vaccine - Market report?

Ans: The main players in the Meningitis B Vaccine - Market are GlaxoSmithKline, Novartis, BEXSERO, TRUMENBA, Pfizer, Sanofi Pasteur Inc, Wyeth Pharmaceuticals, Inc.

What are the Application segmentation covered in the Meningitis B Vaccine - Market report?

Ans: The Applications covered in the Meningitis B Vaccine - Market report are Hospital, Clinic

What are the Type segmentation covered in the Meningitis B Vaccine - Market report?

Ans: The Types covered in the Meningitis B Vaccine - Market report are MenACWY (Conjugate) Vaccine, MenB (Recombinant Protein) Vaccine

1 Market Overview

1.1 Meningitis B Vaccine Product Introduction

1.2 Global Meningitis B Vaccine Market Size Forecast

1.2.1 Global Meningitis B Vaccine Sales Value (2019-2030)

1.2.2 Global Meningitis B Vaccine Sales Volume (2019-2030)

1.2.3 Global Meningitis B Vaccine Sales Price (2019-2030)

1.3 Meningitis B Vaccine Market Trends & Drivers

1.3.1 Meningitis B Vaccine Industry Trends

1.3.2 Meningitis B Vaccine Market Drivers & Opportunity

1.3.3 Meningitis B Vaccine Market Challenges

1.3.4 Meningitis B Vaccine Market Restraints

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Competitive Analysis by Company

2.1 Global Meningitis B Vaccine Players Revenue Ranking (2023)

2.2 Global Meningitis B Vaccine Revenue by Company (2019-2024)

2.3 Global Meningitis B Vaccine Players Sales Volume Ranking (2023)

2.4 Global Meningitis B Vaccine Sales Volume by Company Players (2019-2024)

2.5 Global Meningitis B Vaccine Average Price by Company (2019-2024)

2.6 Key Manufacturers Meningitis B Vaccine Manufacturing Base Distribution and Headquarters

2.7 Key Manufacturers Meningitis B Vaccine Product Offered

2.8 Key Manufacturers Time to Begin Mass Production of Meningitis B Vaccine

2.9 Meningitis B Vaccine Market Competitive Analysis

2.9.1 Meningitis B Vaccine Market Concentration Rate (2019-2024)

2.9.2 Global 5 and 10 Largest Manufacturers by Meningitis B Vaccine Revenue in 2023

2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis B Vaccine as of 2023)

2.10 Mergers & Acquisitions, Expansion

3 Segmentation by Type

3.1 Introduction by Type

3.1.1 MenACWY (Conjugate) Vaccine

3.1.2 MenB (Recombinant Protein) Vaccine

3.2 Global Meningitis B Vaccine Sales Value by Type

3.2.1 Global Meningitis B Vaccine Sales Value by Type (2019 VS 2023 VS 2030)

3.2.2 Global Meningitis B Vaccine Sales Value, by Type (2019-2030)

3.2.3 Global Meningitis B Vaccine Sales Value, by Type (%) (2019-2030)

3.3 Global Meningitis B Vaccine Sales Volume by Type

3.3.1 Global Meningitis B Vaccine Sales Volume by Type (2019 VS 2023 VS 2030)

3.3.2 Global Meningitis B Vaccine Sales Volume, by Type (2019-2030)

3.3.3 Global Meningitis B Vaccine Sales Volume, by Type (%) (2019-2030)

3.4 Global Meningitis B Vaccine Average Price by Type (2019-2030)

4 Segmentation by Application

4.1 Introduction by Application

4.1.1 Hospital

4.1.2 Clinic

4.2 Global Meningitis B Vaccine Sales Value by Application

4.2.1 Global Meningitis B Vaccine Sales Value by Application (2019 VS 2023 VS 2030)

4.2.2 Global Meningitis B Vaccine Sales Value, by Application (2019-2030)

4.2.3 Global Meningitis B Vaccine Sales Value, by Application (%) (2019-2030)

4.3 Global Meningitis B Vaccine Sales Volume by Application

4.3.1 Global Meningitis B Vaccine Sales Volume by Application (2019 VS 2023 VS 2030)

4.3.2 Global Meningitis B Vaccine Sales Volume, by Application (2019-2030)

4.3.3 Global Meningitis B Vaccine Sales Volume, by Application (%) (2019-2030)

4.4 Global Meningitis B Vaccine Average Price by Application (2019-2030)

5 Segmentation by Region

5.1 Global Meningitis B Vaccine Sales Value by Region

5.1.1 Global Meningitis B Vaccine Sales Value by Region: 2019 VS 2023 VS 2030

5.1.2 Global Meningitis B Vaccine Sales Value by Region (2019-2024)

5.1.3 Global Meningitis B Vaccine Sales Value by Region (2025-2030)

5.1.4 Global Meningitis B Vaccine Sales Value by Region (%), (2019-2030)

5.2 Global Meningitis B Vaccine Sales Volume by Region

5.2.1 Global Meningitis B Vaccine Sales Volume by Region: 2019 VS 2023 VS 2030

5.2.2 Global Meningitis B Vaccine Sales Volume by Region (2019-2024)

5.2.3 Global Meningitis B Vaccine Sales Volume by Region (2025-2030)

5.2.4 Global Meningitis B Vaccine Sales Volume by Region (%), (2019-2030)

5.3 Global Meningitis B Vaccine Average Price by Region (2019-2030)

5.4 North America

5.4.1 North America Meningitis B Vaccine Sales Value, 2019-2030

5.4.2 North America Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

5.5 Europe

5.5.1 Europe Meningitis B Vaccine Sales Value, 2019-2030

5.5.2 Europe Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

5.6 Asia Pacific

5.6.1 Asia Pacific Meningitis B Vaccine Sales Value, 2019-2030

5.6.2 Asia Pacific Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

5.7 South America

5.7.1 South America Meningitis B Vaccine Sales Value, 2019-2030

5.7.2 South America Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

5.8 Middle East & Africa

5.8.1 Middle East & Africa Meningitis B Vaccine Sales Value, 2019-2030

5.8.2 Middle East & Africa Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

6 Segmentation by Key Countries/Regions

6.1 Key Countries/Regions Meningitis B Vaccine Sales Value Growth Trends, 2019 VS 2023 VS 2030

6.2 Key Countries/Regions Meningitis B Vaccine Sales Value

6.2.1 Key Countries/Regions Meningitis B Vaccine Sales Value, 2019-2030

6.2.2 Key Countries/Regions Meningitis B Vaccine Sales Volume, 2019-2030

6.3 United States

6.3.1 United States Meningitis B Vaccine Sales Value, 2019-2030

6.3.2 United States Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

6.3.3 United States Meningitis B Vaccine Sales Value by Application, 2023 VS 2030

6.4 Europe

6.4.1 Europe Meningitis B Vaccine Sales Value, 2019-2030

6.4.2 Europe Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

6.4.3 Europe Meningitis B Vaccine Sales Value by Application, 2023 VS 2030

6.5 China

6.5.1 China Meningitis B Vaccine Sales Value, 2019-2030

6.5.2 China Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

6.5.3 China Meningitis B Vaccine Sales Value by Application, 2023 VS 2030

6.6 Japan

6.6.1 Japan Meningitis B Vaccine Sales Value, 2019-2030

6.6.2 Japan Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

6.6.3 Japan Meningitis B Vaccine Sales Value by Application, 2023 VS 2030

6.7 South Korea

6.7.1 South Korea Meningitis B Vaccine Sales Value, 2019-2030

6.7.2 South Korea Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

6.7.3 South Korea Meningitis B Vaccine Sales Value by Application, 2023 VS 2030

6.8 Southeast Asia

6.8.1 Southeast Asia Meningitis B Vaccine Sales Value, 2019-2030

6.8.2 Southeast Asia Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

6.8.3 Southeast Asia Meningitis B Vaccine Sales Value by Application, 2023 VS 2030

6.9 India

6.9.1 India Meningitis B Vaccine Sales Value, 2019-2030

6.9.2 India Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

6.9.3 India Meningitis B Vaccine Sales Value by Application, 2023 VS 2030

7 Company Profiles

7.1 GlaxoSmithKline

7.1.1 GlaxoSmithKline Company Information

7.1.2 GlaxoSmithKline Introduction and Business Overview

7.1.3 GlaxoSmithKline Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.1.4 GlaxoSmithKline Meningitis B Vaccine Product Offerings

7.1.5 GlaxoSmithKline Recent Development

7.2 Novartis

7.2.1 Novartis Company Information

7.2.2 Novartis Introduction and Business Overview

7.2.3 Novartis Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.2.4 Novartis Meningitis B Vaccine Product Offerings

7.2.5 Novartis Recent Development

7.3 BEXSERO

7.3.1 BEXSERO Company Information

7.3.2 BEXSERO Introduction and Business Overview

7.3.3 BEXSERO Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.3.4 BEXSERO Meningitis B Vaccine Product Offerings

7.3.5 BEXSERO Recent Development

7.4 TRUMENBA

7.4.1 TRUMENBA Company Information

7.4.2 TRUMENBA Introduction and Business Overview

7.4.3 TRUMENBA Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.4.4 TRUMENBA Meningitis B Vaccine Product Offerings

7.4.5 TRUMENBA Recent Development

7.5 Pfizer

7.5.1 Pfizer Company Information

7.5.2 Pfizer Introduction and Business Overview

7.5.3 Pfizer Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.5.4 Pfizer Meningitis B Vaccine Product Offerings

7.5.5 Pfizer Recent Development

7.6 Sanofi Pasteur Inc

7.6.1 Sanofi Pasteur Inc Company Information

7.6.2 Sanofi Pasteur Inc Introduction and Business Overview

7.6.3 Sanofi Pasteur Inc Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.6.4 Sanofi Pasteur Inc Meningitis B Vaccine Product Offerings

7.6.5 Sanofi Pasteur Inc Recent Development

7.7 Wyeth Pharmaceuticals, Inc.

7.7.1 Wyeth Pharmaceuticals, Inc. Company Information

7.7.2 Wyeth Pharmaceuticals, Inc. Introduction and Business Overview

7.7.3 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales, Revenue and Gross Margin (2019-2024)

7.7.4 Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Offerings

7.7.5 Wyeth Pharmaceuticals, Inc. Recent Development

8 Industry Chain Analysis

8.1 Meningitis B Vaccine Industrial Chain

8.2 Meningitis B Vaccine Upstream Analysis

8.2.1 Key Raw Materials

8.2.2 Raw Materials Key Suppliers

8.2.3 Manufacturing Cost Structure

8.3 Midstream Analysis

8.4 Downstream Analysis (Customers Analysis)

8.5 Sales Model and Sales Channels

8.5.1 Meningitis B Vaccine Sales Model

8.5.2 Sales Channel

8.5.3 Meningitis B Vaccine Distributors

9 Research Findings and Conclusion

10 Appendix

10.1 Research Methodology

10.1.1 Methodology/Research Approach

10.1.2 Data Source

10.2 Author Details

10.3 Disclaimer

FEATURED COMPANIES

Sanofi Pasteur，Inc.

Wyeth Pharmaceuticals Inc

BEXSERO

TRUMENBA

GlaxoSmithKline PLC

Pfizer Inc

Novartis

List of Tables

Table 1. Meningitis B Vaccine Market Trends

Table 2. Meningitis B Vaccine Market Drivers & Opportunity

Table 3. Meningitis B Vaccine Market Challenges

Table 4. Meningitis B Vaccine Market Restraints

Table 5. Global Meningitis B Vaccine Revenue by Company (2019-2024) & (US$ Million)

Table 6. Global Meningitis B Vaccine Revenue Market Share by Company (2019-2024)

Table 7. Global Meningitis B Vaccine Sales Volume by Company (2019-2024) & (K Units)

Table 8. Global Meningitis B Vaccine Sales Volume Market Share by Company (2019-2024)

Table 9. Global Market Meningitis B Vaccine Price by Company (2019-2024) & (US$/Unit)

Table 10. Key Manufacturers Meningitis B Vaccine Manufacturing Base Distribution and Headquarters

Table 11. Key Manufacturers Meningitis B Vaccine Product Type

Table 12. Key Manufacturers Time to Begin Mass Production of Meningitis B Vaccine

Table 13. Global Meningitis B Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Meningitis B Vaccine as of 2023)

Table 15. Mergers & Acquisitions, Expansion Plans

Table 16. Global Meningitis B Vaccine Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)

Table 17. Global Meningitis B Vaccine Sales Value by Type (2019-2024) & (US$ Million)

Table 18. Global Meningitis B Vaccine Sales Value by Type (2025-2030) & (US$ Million)

Table 19. Global Meningitis B Vaccine Sales Market Share in Value by Type (2019-2024) & (%)

Table 20. Global Meningitis B Vaccine Sales Market Share in Value by Type (2025-2030) & (%)

Table 21. Global Meningitis B Vaccine Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)

Table 22. Global Meningitis B Vaccine Sales Volume by Type (2019-2024) & (K Units)

Table 23. Global Meningitis B Vaccine Sales Volume by Type (2025-2030) & (K Units)

Table 24. Global Meningitis B Vaccine Sales Market Share in Volume by Type (2019-2024) & (%)

Table 25. Global Meningitis B Vaccine Sales Market Share in Volume by Type (2025-2030) & (%)

Table 26. Global Meningitis B Vaccine Price by Type (2019-2024) & (US$/Unit)

Table 27. Global Meningitis B Vaccine Price by Type (2025-2030) & (US$/Unit)

Table 28. Global Meningitis B Vaccine Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)

Table 29. Global Meningitis B Vaccine Sales Value by Application (2019-2024) & (US$ Million)

Table 30. Global Meningitis B Vaccine Sales Value by Application (2025-2030) & (US$ Million)

Table 31. Global Meningitis B Vaccine Sales Market Share in Value by Application (2019-2024) & (%)

Table 32. Global Meningitis B Vaccine Sales Market Share in Value by Application (2025-2030) & (%)

Table 33. Global Meningitis B Vaccine Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)

Table 34. Global Meningitis B Vaccine Sales Volume by Application (2019-2024) & (K Units)

Table 35. Global Meningitis B Vaccine Sales Volume by Application (2025-2030) & (K Units)

Table 36. Global Meningitis B Vaccine Sales Market Share in Volume by Application (2019-2024) & (%)

Table 37. Global Meningitis B Vaccine Sales Market Share in Volume by Application (2025-2030) & (%)

Table 38. Global Meningitis B Vaccine Price by Application (2019-2024) & (US$/Unit)

Table 39. Global Meningitis B Vaccine Price by Application (2025-2030) & (US$/Unit)

Table 40. Global Meningitis B Vaccine Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)

Table 41. Global Meningitis B Vaccine Sales Value by Region (2019-2024) & (US$ Million)

Table 42. Global Meningitis B Vaccine Sales Value by Region (2025-2030) & (US$ Million)

Table 43. Global Meningitis B Vaccine Sales Value by Region (2019-2024) & (%)

Table 44. Global Meningitis B Vaccine Sales Value by Region (2025-2030) & (%)

Table 45. Global Meningitis B Vaccine Sales Volume by Region (K Units): 2019 VS 2023 VS 2030

Table 46. Global Meningitis B Vaccine Sales Volume by Region (2019-2024) & (K Units)

Table 47. Global Meningitis B Vaccine Sales Volume by Region (2025-2030) & (K Units)

Table 48. Global Meningitis B Vaccine Sales Volume by Region (2019-2024) & (%)

Table 49. Global Meningitis B Vaccine Sales Volume by Region (2025-2030) & (%)

Table 50. Global Meningitis B Vaccine Average Price by Region (2019-2024) & (US$/Unit)

Table 51. Global Meningitis B Vaccine Average Price by Region (2025-2030) & (US$/Unit)

Table 52. Key Countries/Regions Meningitis B Vaccine Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030

Table 53. Key Countries/Regions Meningitis B Vaccine Sales Value, (2019-2024) & (US$ Million)

Table 54. Key Countries/Regions Meningitis B Vaccine Sales Value, (2025-2030) & (US$ Million)

Table 55. Key Countries/Regions Meningitis B Vaccine Sales Volume, (2019-2024) & (K Units)

Table 56. Key Countries/Regions Meningitis B Vaccine Sales Volume, (2025-2030) & (K Units)

Table 57. GlaxoSmithKline Company Information

Table 58. GlaxoSmithKline Introduction and Business Overview

Table 59. GlaxoSmithKline Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 60. GlaxoSmithKline Meningitis B Vaccine Product Offerings

Table 61. GlaxoSmithKline Recent Development

Table 62. Novartis Company Information

Table 63. Novartis Introduction and Business Overview

Table 64. Novartis Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 65. Novartis Meningitis B Vaccine Product Offerings

Table 66. Novartis Recent Development

Table 67. BEXSERO Company Information

Table 68. BEXSERO Introduction and Business Overview

Table 69. BEXSERO Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 70. BEXSERO Meningitis B Vaccine Product Offerings

Table 71. BEXSERO Recent Development

Table 72. TRUMENBA Company Information

Table 73. TRUMENBA Introduction and Business Overview

Table 74. TRUMENBA Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 75. TRUMENBA Meningitis B Vaccine Product Offerings

Table 76. TRUMENBA Recent Development

Table 77. Pfizer Company Information

Table 78. Pfizer Introduction and Business Overview

Table 79. Pfizer Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 80. Pfizer Meningitis B Vaccine Product Offerings

Table 81. Pfizer Recent Development

Table 82. Sanofi Pasteur Inc Company Information

Table 83. Sanofi Pasteur Inc Introduction and Business Overview

Table 84. Sanofi Pasteur Inc Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 85. Sanofi Pasteur Inc Meningitis B Vaccine Product Offerings

Table 86. Sanofi Pasteur Inc Recent Development

Table 87. Wyeth Pharmaceuticals, Inc. Company Information

Table 88. Wyeth Pharmaceuticals, Inc. Introduction and Business Overview

Table 89. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)

Table 90. Wyeth Pharmaceuticals, Inc. Meningitis B Vaccine Product Offerings

Table 91. Wyeth Pharmaceuticals, Inc. Recent Development

Table 92. Key Raw Materials Lists

Table 93. Raw Materials Key Suppliers Lists

Table 94. Meningitis B Vaccine Downstream Customers

Table 95. Meningitis B Vaccine Distributors List

Table 96. Research Programs/Design for This Report

Table 97. Key Data Information from Secondary Sources

Table 98. Key Data Information from Primary Sources

List of Figures

Figure 1. Meningitis B Vaccine Product Picture

Figure 2. Global Meningitis B Vaccine Sales Value, 2019 VS 2023 VS 2030 (US$ Million)

Figure 3. Global Meningitis B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 4. Global Meningitis B Vaccine Sales Volume (2019-2030) & (K Units)

Figure 5. Global Meningitis B Vaccine Sales Price (2019-2030) & (US$/Unit)

Figure 6. Meningitis B Vaccine Report Years Considered

Figure 7. Global Meningitis B Vaccine Players Revenue Ranking (2023) & (US$ Million)

Figure 8. Global Meningitis B Vaccine Players Sales Volume Ranking (2023) & (K Units)

Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Meningitis B Vaccine Revenue in 2023

Figure 10. Meningitis B Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023

Figure 11. MenACWY (Conjugate) Vaccine Picture

Figure 12. MenB (Recombinant Protein) Vaccine Picture

Figure 13. Global Meningitis B Vaccine Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)

Figure 14. Global Meningitis B Vaccine Sales Value Market Share by Type, 2023 & 2030

Figure 15. Global Meningitis B Vaccine Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)

Figure 16. Global Meningitis B Vaccine Sales Volume Market Share by Type, 2023 & 2030

Figure 17. Global Meningitis B Vaccine Price by Type (2019-2030) & (US$/Unit)

Figure 18. Product Picture of Hospital

Figure 19. Product Picture of Clinic

Figure 20. Global Meningitis B Vaccine Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)

Figure 21. Global Meningitis B Vaccine Sales Value Market Share by Application, 2023 & 2030

Figure 22. Global Meningitis B Vaccine Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)

Figure 23. Global Meningitis B Vaccine Sales Volume Market Share by Application, 2023 & 2030

Figure 24. Global Meningitis B Vaccine Price by Application (2019-2030) & (US$/Unit)

Figure 25. North America Meningitis B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 26. North America Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 27. Europe Meningitis B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 28. Europe Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 29. Asia Pacific Meningitis B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 30. Asia Pacific Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 31. South America Meningitis B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 32. South America Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 33. Middle East & Africa Meningitis B Vaccine Sales Value (2019-2030) & (US$ Million)

Figure 34. Middle East & Africa Meningitis B Vaccine Sales Value by Country (%), 2023 VS 2030

Figure 35. Key Countries/Regions Meningitis B Vaccine Sales Value (%), (2019-2030)

Figure 36. Key Countries/Regions Meningitis B Vaccine Sales Volume (%), (2019-2030)

Figure 37. United States Meningitis B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 38. United States Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 39. United States Meningitis B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 40. Europe Meningitis B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 41. Europe Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 42. Europe Meningitis B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 43. China Meningitis B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 44. China Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 45. China Meningitis B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 46. Japan Meningitis B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 47. Japan Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 48. Japan Meningitis B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 49. South Korea Meningitis B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 50. South Korea Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 51. South Korea Meningitis B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 52. Southeast Asia Meningitis B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 53. Southeast Asia Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 54. Southeast Asia Meningitis B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 55. India Meningitis B Vaccine Sales Value, (2019-2030) & (US$ Million)

Figure 56. India Meningitis B Vaccine Sales Value by Type (%), 2023 VS 2030

Figure 57. India Meningitis B Vaccine Sales Value by Application (%), 2023 VS 2030

Figure 58. Meningitis B Vaccine Industrial Chain

Figure 59. Meningitis B Vaccine Manufacturing Cost Structure

Figure 60. Channels of Distribution (Direct Sales, and Distribution)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3950

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5925

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$7900

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions